BioMed Research International / 2018 / Article / Tab 1

Research Article

Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity

Table 1

Relationship between clinicopathological characteristics and serum alpha-L-fucosidase (AFU) level in 148 patients with intrahepatic cholangiocarcinoma (iCCA).

VariablesNumberAFU (U/L) value
<20.85≥20.85

Age (years)
 <609145 (69.2)46 (55.4)0.087
 ≥605720 (30.8)37 (44.6)
Sex
 Female5423 (35.4)31 (37.3)0.623
 Male9442 (64.6)52 (62.7)
Lymph node metastasis
 No10547 (72.3)58 (69.9)0.747
 Yes4318 (27.7)25 (30.1)
Tumor number
 Solitary9541 (63.1)54 (65.1)0.803
 Multiple5324 (36.9)29 (34.9)
ALT (U/L)
 ≤4011251 (78.5)61 (73.5)0.485
 >403614 (21.5)22 (26.5)
AST (U/L)
 ≤4513261 (93.8)71 (85.5)0.106
 >45164 (6.2)12 (14.5)
Tumor size (cm)
 ≤55723 (35.4)34 (41)0.489
 >59142 (64.6)49 (59)
TNM stage
 I4624 (36.9)22 (26.5)0.174
 II–IV10241 (63.1)61 (73.5)
CA19-9 (U/mL)
 <1009440 (61.5)54 (65.1)0.659
 ≥1005425 (38.5)29 (34.9)

AST: aspartate transaminase; ALT: alanine aminotransferase; CA19-9: carbohydrate antigen 19-9.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.